Manufacturer of Lidocaine Hydrochloride and Dextrose Injection

This subcontract with the Department of Defense Medical Supply Chain Pharmacy FSA involves the manufacture and supply of sterile, nonpyrogenic injectable medication for prime contractors. The scope of work requires the production of a solution containing 2g Lidocaine Hydrochloride USP and 5g Hydrous Dextrose USP at a 4 mg/mL concentration, filled into 500 ML single-dose bags. To ensure patient safety and quality, the manufacturing process must utilize latex-free, DEHP-free, and PVC-free systems within a sterile cleanroom environment. The selected provider must maintain a valid FDA license and strictly adhere to USP standards. Deliverables consist of packages containing 24 single-dose bags each. This opportunity falls under NAICS code 325412 and is associated with performance in APO 09227.